Achieve Life Sciences (STU:SP4P) Cyclically Adjusted Book per Share: €137.38 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:SP4P Achieve Life Sciences Inc STU:SP4P
38 GF Score
Price €6.95
! 4 Warning Signs
View Full Analysis

What is Achieve Life Sciences Cyclically Adjusted Book per Share?

Achieve Life Sciences STU:SP4P +2.96% 38 Cyclically Adjusted Book per Share is €137.38 as of Jun. 2026. GuruFocus rates STU:SP4P with a GF Score™ of 38/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Achieve Life Sciences's adjusted book value per share for the three months ended in Jun. 2026 was €-0.124. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €137.38 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Achieve Life Sciences's average Cyclically Adjusted Book Growth Rate was -67.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -46.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -40.30% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -29.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Achieve Life Sciences was 10.80% per year. The lowest was -46.50% per year. And the median was -15.30% per year.

As of today (2026-08-26), Achieve Life Sciences's current stock price is €6.95. Achieve Life Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was €137.38. Achieve Life Sciences's Cyclically Adjusted PB Ratio of today is 0.05.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Achieve Life Sciences was 0.13. The lowest was 0.01. And the median was 0.04.


Achieve Life Sciences  (STU:SP4P) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Achieve Life Sciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=6.95/137.38
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Achieve Life Sciences was 0.13. The lowest was 0.01. And the median was 0.04.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Achieve Life Sciences Cyclically Adjusted Book per Share Related Terms


Achieve Life Sciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Achieve Life Sciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Achieve Life Sciences Cyclically Adjusted Book per Share Chart

Achieve Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,579.85 1,869.83 1,000.25 638.30 223.02

Achieve Life Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 387.68 316.94 223.02 191.48 137.38

STU:SP4P vs MDXG, RGNX, AGMB: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Achieve Life Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Achieve Life Sciences Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Achieve Life Sciences's Cyclically Adjusted PB Ratio falls into.


STU:SP4P
38GF Score
Achieve Life Sciences Inc STU:SP4P
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Achieve Life Sciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Achieve Life Sciences's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.124/333.9520*333.9520
=-0.124

Current CPI (Jun. 2026) = 333.9520.

Achieve Life Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201609 1,554.071 241.428 2,149.648
201612 41.286 241.432 57.107
201703 1,061.286 243.801 1,453.721
201706 833.000 244.955 1,135.645
201709 157.228 246.819 212.733
201712 110.967 246.524 150.321
201803 77.828 249.554 104.149
201806 66.387 251.989 87.980
201809 49.547 252.439 65.546
201812 41.339 251.233 54.950
201903 26.836 254.202 35.255
201906 25.138 256.143 32.774
201909 18.252 256.759 23.739
201912 11.021 256.974 14.322
202003 8.649 258.115 11.190
202006 6.662 257.797 8.630
202009 6.028 260.280 7.734
202012 5.015 260.474 6.430
202103 4.110 264.877 5.182
202106 3.587 271.696 4.409
202109 3.120 274.310 3.798
202112 2.625 278.802 3.144
202203 2.054 287.504 2.386
202206 1.286 296.311 1.449
202209 0.109 296.808 0.123
202212 0.438 296.797 0.493
202303 0.023 301.836 0.025
202306 0.424 305.109 0.464
202309 0.179 307.789 0.194
202312 -0.063 306.746 -0.069
202403 1.328 312.332 1.420
202406 1.144 314.175 1.216
202409 0.822 315.301 0.871
202412 0.575 315.605 0.608
202503 0.274 319.799 0.286
202506 0.727 322.561 0.753
202509 0.542 324.800 0.557
202512 0.345 324.054 0.356
202603 0.173 330.213 0.175
202606 -0.124 333.952 -0.124

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €137.38 mean?
Achieve Life Sciences (STU:SP4P) has a Cyclically Adjusted Book per Share of €137.38 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Achieve Life Sciences and its competitors.
Is Achieve Life Sciences' Cyclically Adjusted Book per Share too high?
Achieve Life Sciences' current Cyclically Adjusted Book per Share is €137.38. Overall, Achieve Life Sciences has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Achieve Life Sciences' Cyclically Adjusted Book per Share compare to MDXG and RGNX?
Achieve Life Sciences' Cyclically Adjusted Book per Share of €137.38 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Achieve Life Sciences and its competitors. Achieve Life Sciences's current Cyclically Adjusted Book per Share is €137.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Achieve Life Sciences stock overvalued right now?
Achieve Life Sciences (STU:SP4P) has a current Cyclically Adjusted Book per Share of €137.38. The current Cyclically Adjusted Book per Share is €137.38. Achieve Life Sciences' overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Achieve Life Sciences (STU:SP4P), the current Cyclically Adjusted Book per Share is €137.38 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Achieve Life Sciences Business Description

Other Exchanges ACHV:USASP4P:Germany
Address 22722 29th Drive SE, Suite 100, Bothell, WA, USA, 98021
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
38GF Score

Get the complete analysis for STU:SP4P

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.95
Price